Invasive fungal infections constitute a serious threat to an ever-growing population of
immunocompromised individuals and other individuals at risk. Traditional diagnostic …

Background Community-acquired pneumonia (CAP) guidelines have improved the
treatment and outcomes of patients with CAP, primarily by standardization of initial empirical …

Although the incidence of Pneumocystis pneumonia (PCP) has decreased since the
introduction of combination antiretroviral therapy, it remains an important cause of disease in …

Pneumocystis has gained attention during the last decade in the context of the AIDS
epidemic and the increasing use of cytotoxic and immunosuppressive therapies. The …

Diagnosis of pneumocystosis usually relies on microscopic demonstration of Pneumocystis
jirovecii in respiratory samples. Conventional PCR can detect low levels of P. jirovecii DNA …

Pneumocystis jirovecii pneumonia (PCP) is an acute and life-threatening lung disease
caused by the fungus Pneumocystis jirovecii. The presentation of PCP in HIV-positive …

Background Pneumocystis pneumonia (PCP) is one of the most devastating fungal diseases
in patients with impaired immunity. Effective antiviral therapies have reduced the burden of …

In human immunodeficiency virus (HIV)-infected patients, Pneumocystis jirovecii pneumonia
(PCP) is a well-known opportunistic infection, and its management has been established …

Laboratory diagnostics are a core component of any pneumonia etiology study. Recent
advances in diagnostic technology have introduced newer methods that have greatly …

HIV-negative populations at risk for PJP can be identified. Conventional PCR increases
diagnostic sensitivity but may detect asymptomatic colonization. Quantitative PCR …